N-glycan microheterogeneity regulates interactions of plasma proteins
Open Access
- 15 August 2018
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (35) , 8763-8768
Abstract
Significance: Glycosylation is one of the most common and complex posttranslation modifications that significantly influences protein structure and function. However, linking individual glycan structures to protein interactions remains challenging and typically requires multiple techniques. Here, we establish a mass-spectrometric approach to systematically dissect the microheterogeneity of two important serum proteins, α1-acid glycoprotein and haptoglobin, and relate glycan features to drug and protein-binding interaction kinetics. We found that the degree of N-glycan branching and extent of terminal fucosylation can attenuate or enhance these interactions, providing important insight into drug transport in plasma. Our study demonstrates an approach capable of investigating how protein glycosylation fine-tunes protein–drug interactions at the glycan-specific level and will prove universally useful for studying glycoprotein interactions.Keywords
Funding Information
- Wellcome Trust (104633/Z/14/Z)
This publication has 56 references indexed in Scilit:
- The Glycosylation of AGP and Its Associations with the Binding to MethadoneBioMed Research International, 2013
- The sweet and sour of serological glycoprotein tumor biomarker quantificationBMC Medicine, 2013
- Galectin-1-Binding Glycoforms of Haptoglobin with Altered Intracellular Trafficking, and Increase in Metastatic Breast Cancer PatientsPLOS ONE, 2011
- Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot databaseScientific Reports, 2011
- Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cellsProceedings of the National Academy of Sciences, 2011
- Structural Insights into Differences in Drug-binding Selectivity between Two Forms of Human α1-Acid Glycoprotein Genetic Variants, the A and F1*S FormsJournal of Biological Chemistry, 2011
- Glycosylation of Therapeutic ProteinsBioDrugs, 2010
- Metabolism, Cell Surface Organization, and DiseaseCell, 2009
- Knockdown of GnT-Va expression inhibits ligand-induced downregulation of the epidermal growth factor receptor and intracellular signaling by inhibiting receptor endocytosisGlycobiology, 2009
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004